In a new genetic study, researchers said they may have found a way to cut the cost of genetic screening for breast and ovarian cancers from $3000 to $400. Three teams of infertility scientists in New York and Austria collaborated to study gene mutations that increase a woman's likelihood of breast and ovarian cancers... read more..
Breast and ovarian cancer are linked by a genetic mutation. This genetic disorder raises your risk for breast and ovarian cancer, if you carry it. With genetic testing, you can find out more about your risk for these cancers. (Source: About.com Breast Cancer) read more..
Conclusions:These results suggest that the ClinProt Kit combined with MS shows great potentiality for thediagnosis of breast cancer.Virtual slidesThe virtual slide(s) for this article can be found here:http://www.diagnosticpathology.diagnomx.eu/vs/1501556838687844 (Source: Diagnostic Pathology) read more..
Scientists have uncovered a marker of DNA damage that could predict who will respond to platinum-based chemotherapy drugs like cisplatin or carboplatin. These drugs are widely used for ovarian cancer, but as with most cancer drugs, it can be difficult to predict who will respond to therapy... read more..
Every new imaging technology has an aura of magic about it because it suddenly reveals what had been concealed, and makes visible what had been invisible. So, too, with photoacoustic tomography, which is allowing scientists to virtually peel away the top several inches of flesh to see what lies beneath... read more..
